Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study. [PDF]
Eviatar T +35 more
europepmc +1 more source
Genotype-phenotype correlations in pediatric CAPS with predominantly low-penetrance NLRP3 variants among Turkish patients in Germany and Turkey: beyond borders. [PDF]
Bayindir Y +6 more
europepmc +1 more source
The promise of IL-1β modulation in NSCLC clinical context. [PDF]
Ghiringhelli F, Rébé C.
europepmc +1 more source
Refractory recurrent pericarditis associated with MEFV E148Q variant: selective response to IL-1 receptor antagonism. [PDF]
Haider SW.
europepmc +1 more source
Therapeutic Targeting of Inflammaging and Emerging Strategies for Managing Age-Related Multimorbidity: A Narrative Review. [PDF]
Ayoub NR.
europepmc +1 more source
Targeting Inflammation in Atherosclerosis: Mechanistic Rationale, Clinical Trials, and Regulatory Considerations. [PDF]
Mandinov L, Learn CA.
europepmc +1 more source
Three-year follow-up of canakinumab dose extension in children with colchicine-resistant familial Mediterranean fever: PeRA-RG Experience. [PDF]
Kavrul Kayaalp G +14 more
europepmc +1 more source
PAPASH-like disease associated with a heterozygous NLRP1 variant complicated by papulopustular folliculitis. [PDF]
Alicea-Negrón AJ +4 more
europepmc +1 more source
Early intensification versus step-up biologic strategies in systemic juvenile idiopathic arthritis: a Bayesian network meta-analysis of remission and safety outcomes. [PDF]
Liu X, Yang L, Huang H.
europepmc +1 more source
Therapeutic Applications of Immunobiologics in Autoimmune and Inflammatory Diseases. [PDF]
Narayanan KB.
europepmc +1 more source

